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Oxidative stress markers as well as high concentra-
tions of copper are found in the vicinity of Ab amyloid
deposits in Alzheimer’s disease. The neurotoxicity of Ab
in cell culture has been linked to H2O2 generation by an
unknown mechanism. We now report that Cu(II) mark-
edly potentiates the neurotoxicity exhibited by Ab in
cell culture. The potentiation of toxicity is greatest for
Ab1–42 > Ab1–40 >> mouse/rat Ab1–40, corresponding
to their relative capacities to reduce Cu(II) to Cu(I),
form H2O2 in cell-free assays and to exhibit amyloid
pathology. The copper complex of Ab1–42 has a highly
positive formal reduction potential ('1500–550 mV ver-
sus Ag/AgCl) characteristic of strongly reducing cupro-
proteins. These findings suggest that certain redox ac-
tive metal ions may be important in exacerbating and
perhaps facilitating Ab-mediated oxidative damage in
Alzheimer’s disease.
Oxidative damage in the neocortex coincides with Ab accu-
mulation both in Alzheimer’s disease (AD)1 (1) and in Ab amy-
loid-bearing transgenic mice (2), but the mechanisms of oxida-
tion are unknown. The possibility that Ab accumulation causes
oxidation, perhaps by radical formation (3), has been explored,
but the nature of the chemistry involved in generating Ab-
associated oxidation products such as lipid peroxides (4) re-
mains to be elaborated. In culture, Ab-induced neurotoxicity is
characterized by elevated cellular H2O2 and is combated by
antioxidants such as vitamin E and catalase (5). The origin of
the toxic H2O2 is unknown.
Recently, we reported that Fe(III) interacts directly with
Ab1–42 and Ab1–40 to produce H2O2 and TBARS formation in
a cell-free manner in vitro, through reduction of the metal ion
(6), suggesting that a source of the H2O2 that mediates toxicity
in cell cultures exposed to Ab is extracellular. Cu(II)and Fe(III)
have been found in abnormally high concentrations in amyloid
plaques ('0.4 and '1 mM, respectively) and AD-affected neu-
ropil (7), and copper-selective chelators have been shown to
dissolve Ab deposits extracted from AD post-mortem brain
specimens (8). Therefore, these metal ions may be important
cofactors in Ab-associated oxidative damage. Importantly, we
have also reported that the generation of both Cu(II) and
Fe(III)-mediated TBARS is greatest for Ab1–42 . Ab1–40 ..
rat Ab1–40 (6). This rank order is of interest because it mirrors
the relative participation of the peptides in amyloid neuropa-
thology, and because the most active one (Ab1–42) is overpro-
duced in familial AD (9). Rats and mice do not develop amyloid
(10), even in mice transgenic for familial-AD linked mutant
presenilin that overexpress endogenous mouse Ab1–42 (11),
probably due to the three amino acid substitutions in their
homologue of Ab (Arg5 3 Gly, Tyr10 3 Phe, and His13 3 Arg)
(12).
Although Fe(III) mediates and potentiates Ab1–40 toxicity
in cell culture (13), it is not clear whether this is due to metal
interaction with the peptide or due to a nonspecific increase in
reactive oxygen species (ROS) generation within the cell. Redox
active metal ions, such as Cu(II) and Fe(III), play an obligatory
role in generating ROS, and in mediating ROS-induced damage
(e.g. the Fenton reaction) (14, 15). Similarly, the Cu(II) and
Fe(III) enhancement of dichlorofluorescein (DCF)-reactive ox-
ygen species generated by Ab25–35 treatment of post-mito-
chondrial rat cerebrocortex (16) could be due to catalytically
enhanced ROS generation within the tissue, rather than due to
metal interaction with the peptide.
Cu(II) causes the peptide to aggregate to a greater extent
than Fe(III) (Ab1–42 . Ab1–40 . rat Ab1–40) (17), a property
that may be related to the relative affinities of the metal ions
* This work was supported in part by grants from Prana Corp.; NIA,
National Institutes of Health; Alliance for Aging Research (Paul Beeson
Physician Faculty Scholar in Aging research award to A. I. B.); Inter-
national Life Sciences Institute; the National Health and Medical Re-
search Council of Australia; the Australian Research Council; and the
Commonwealth of Massachusetts Research Center. The costs of publi-
cation of this article were defrayed in part by the payment of page
charges. This article must therefore be hereby marked “advertisement”
in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
b Recipient of a National Research Service Award (NIA, National
Institutes of Health).
h Massachusetts General Hospital Medical Fund for Discovery fellow.
k To whom correspondence should be addressed: Laboratory for Oxi-
dation Biology, Genetics and Aging Unit, Massachusetts General Hos-
pital East, Bldg. 149, 13th St., Charlestown, MA 02129. Tel.: 617-726-
8244; Fax: 617-724-9610; E-mail: bush@helix.mgh.harvard.edu.
1 The abbreviations used are: AD, Alzheimer’s disease; TBARS, thio-
barbituric acid-reactive substance; ROS, reactive oxygen species; DCF,
dichlorofluorescein; BC, bathocuproine disulfonic acid; BCA, bicincho-
ninic acid; PBS, phosphate-buffered saline.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 274, No. 52, Issue of December 24, pp. 37111–37116, 1999
© 1999 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
This paper is available on line at http://www.jbc.org 37111
 at UQ Library on November 1, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
for Ab. We hypothesize that if such redox active metal ions bind
to Ab peptides with high affinity and become more oxidizing,
they may potentiate Ab-induced cytotoxicity. Furthermore, if
the redox competence of Ab is responsible for its neurotoxicity,
then toxicity should be greatest for Ab1–42 . Ab1–40 . rat
Ab1–40. Ab1–42 has been reported to be more neurotoxic than
Ab1–40 (18), but a comparison of the neurotoxicity of these
three peptides, or the effects of Cu(II) upon the potentiation of
their respective toxicities in culture, has not yet been reported
to our knowledge.
Here we report that, in the presence of Cu(II), Ab is indeed
redox-competent (Ab1–42 . Ab1–40 .. rat Ab1–40), and that
a series of electron transfer reactions occur when Cu(II) binds
to Ab, including reduction to Cu(I) and consequent O2-depend-
ent, cell-free peroxide formation. These changes correlate with
a striking potentiation in the neurotoxicities of the respective
Ab species in cell culture, supporting an extracellular origin for
the H2O2 that mediates Ab-induced toxicity. These data sug-
gest that formation of an Ab-copper complex may be a patho-
physiological interaction, and a new target for therapeutic in-
terdiction in AD.
EXPERIMENTAL PROCEDURES
Reagents—Ab peptides 1–40 and 1–42 were synthesized by the W.
Keck Laboratory, Yale University, New Haven, CT. Confirmatory data
were obtained by reproducing experiments with Ab peptides synthe-
sized and obtained from other sources: Glabe Laboratory, University of
California, Irvine, CA; Multhaup Laboratory, University of Heidelberg;
U.S. Peptides, Bachem (Torrance, CA); and Sigma. Rat Ab1–40 was
synthesized and purified by the Multhaup Laboratory. For the EPR
experiments, Ab1–40 was synthesized at the University of Queensland.
Ab1–28 and Ab25–35 were purchased from U.S. Peptides, Bachem, and
Sigma. Ab40–1 was purchased from Bachem, and also synthesized by
the Multhaup Laboratory (giving corroborating results). Ab peptide
stock solutions were prepared in water treated with Chelex-100 resin
(Bio-Rad) and quantified, according to established procedures (17).
Cu(II)-Gly stock solutions were used to prevent metal-hydroxy and
metal-oxy polymers that form in neutral metal ion solutions and were
prepared by mixing National Institute of Standards and Technology
(NIST) standard copper with glycine at metal/ligand molar ratio of 1:6.
Other reagents are from Sigma, unless otherwise mentioned.
Metal Reduction Assays—Assays were performed using a 96-well
microtiter plate (Costar), based upon a modification of established
protocols (19). Polypeptides (10 mM) or vitamin C (10 mM), Cu(II)-glycine
and Cu(I) indicator (250 mM), either bathocuproine disulfonic acid (BC)
or bicinchoninic acid (BCA, 4,49-dicarboxy-2,29-biquinoline), were coin-
cubated in Dulbecco’s phosphate-buffered saline (PBS: 1.19 mM CaCl2,
0.6 mM MgCl2, 2.7 mM KCl, 1.4 mM KH2PO4, 137 mM NaCl, 7.68 mM
Na2HPO4, pH 7.4), at 37 °C. Absorbances were then measured using a
plate reader (SPECTRAmax Plus, Molecular Devices). In control sam-
ples, both metal ion and indicator were present to determine the back-
ground buffer signal. Absorbance of metal ion and peptide present in
the absence of indicator were taken to estimate the contribution of light
scattering due to turbidity. The net absorbances (A) were obtained by
deducting the absorbances from these controls from the absorbances
generated by the peptide and metal in the presence of the indicator.
Cu(I) concentrations (mM) were calculated as A 3 106/M, where M is the
known molar absorption coefficient (M21 cm21). For Cu(I)-BC, M 5
12,250 at 483 nm; and for Cu(I)-BCA, M 5 7700 at 562 nm.
Cyclic Voltammetry—Cyclic voltammograms were obtained at room
temperature (22 6 2 °C) on air-equilibrated solutions using an EG&G
PARC potentiostat, model 263A. The electrochemical cell incorporated
an indium/tin oxide working electrode (Donnelly Corp.) of 0.32-cm2
area, a platinum auxiliary electrode, and a Ag/AgCl (1 M KCl) reference
electrode. Indium/tin oxide electrodes were pretreated by successive 30
min sonications in Alconox solution (8 g/liter), 95% ethanol, Milli-Q
water, and PBS, pH 7.3, followed by overnight equilibration in PBS.
The peptide solution was prepared by first dissolving Ab1–42 with
sonication in double-distilled water to 300 mM, after which the peptide
solution was added to Dulbecco’s phosphate-buffered saline without
calcium or magnesium (Sigma) to a final concentration of 100 mM.
Background voltammograms were first acquired in buffer on each new
electrode used, followed by examination of Ab1–42 (100 mM) in buffer,
CuCl2 (17 mM) in buffer, and Ab1–42 (100 mM) with added CuCl2 (17 mM)
in buffer. The possibility that the formal potentials measured were for
surface-adsorbed complexes cannot be excluded, and, in fact, the wave
shapes (Fig. 3, lines c and d) are suggestive of involvement by adsorbed
species. Further investigation is planned to resolve this issue.
Electron Paramagnetic Resonance—Ab1–40 (0.42 mg) was dissolved
in 300 ml of PBS buffer (20 mM Na2HPO4, 20 mM NaH2PO4, 150 mM
NaCl, pH 7.4) to which CuCl2 (as indicated) was later added. Q-, X-, and
S- band EPR spectra were recorded on a Bruker ESP300E EPR spec-
trometer; the magnetic field and microwave frequency were calibrated
with a Bruker ER-035M gaussmeter and an EIP 548B microwave
frequency counter. Quantitation of the Cu(II)-Ab1–40 EPR resonance
was performed by a comparison method (20) using an X-band dual
TE104 rectangular cavity with TEMPO as reference sample. The indi-
vidual cavities have different modulation amplitudes, which can be
calibrated, and different microwave magnetic strengths (B1), which
was overcome by measuring standard and reference samples in each
cavity. The doubly integrated areas are proportional to the spin con-
centration and were normalized for the anisotropic probability ,g1
2.
and instrument settings. The relative areas can then be used to calcu-
late the concentration of Cu(II)-peptide that produces the residual
spectrum. The anisotropic spectra of the Cu(II)-AB1–40 complexes
were measured at 130 K using a flow-through cryostat. Spin Hamilto-
nian parameters were extracted from the spectra with the XSophe/
Sophe computer simulation software suite (21). Buffers were demetal-
lated with Chelex 100 resin.
Cell Culture—Rat embryonic day 17 forebrain neuronal cultures
were grown at 95% O2, 5% CO2, 85% humidity for 4 days in serum-free
NeurobasalTM medium with B-27 supplement (Life Technologies, Inc.),
20 mM L-glutamate, 100 units/ml penicillin, 0.1 g/ml streptomycin, and
2 mM L-glutamine. On the fifth day (treatment day), the medium was
replaced with serum-free NeurobasalTM plus L-glutamine without B-27
supplement (vehicle medium). Stock solutions were mixed in vehicle
medium to a final concentration of peptide or copper-glycine. Experi-
mental trials were done in triplicate wells. Viable cells were counted
manually using a 1-mm2 grid (103 objective) stained with either cal-
cein-AM (Live/DeadTM assay, Molecular Probes) or trypan blue. Data
were analyzed using one-way analysis of variance followed by post-hoc
Student-Newman-Keuls method and/or Student’s t test. Significance
level was set at p , 0.05.
Hydrogen Peroxide Assays—The colorimetric H2O2 assay was per-
formed in a 96-well microtiter plate (SpectraMax Plus, Molecular De-
vices), according to a modification of an existing protocol (22). Polypep-
tides (10 mM) or vitamin C (10 mM), Cu(II) (1 mM), and a H2O2 scavenging
agent, tris(2-carboxyethyl)phosphine hydrochloride (Pierce, 50 mM),
were co-incubated in PBS buffer (300 ml), pH 7.4, for 1 h at 37 °C.
Following incubation, the unreacted tris(2-carboxyethyl)phosphine hy-
drochloride was detected by 5,59-dithiobis(2-nitrobenzoic acid) (Sigma,
50 mM). The amount of H2O2 produced was quantified based on the
formula: H2O2 (mM) 5 A 3 10
6/(2 3 L 3 M), where A is the absolute
absorbance difference between a sample and catalase-only (Sigma, 100
units/ml) control at 412 nm; L 5 the vertical pathlength, corrected
automatically by the plate reader to 1 cm; M is the molecular absorb-
ance for 2-nitro-5-thiobenzoate (14,150 M21 cm21 at 412 nm).
For the DCF assay, 5 mM of 29,79-dichlorofluorescin diacetate (Mo-
lecular Probes) in 100% ethanol was de-acetylated by 0.01 M NaOH for
0.5 h, 200 units/ml horseradish peroxidase was then added, and the
DCF solution was neutralized and diluted to 200 mM by PBS before use.
Then 20 mM DCF, 10 mM Ab1–42, and 1 mM Cu(II)-glycine were co-
incubated at 37 °C for 20 min in PBS. Catalase (1000 units/ml) with or
without heat inactivation (100 °C for 30 min) was used to validate the
signal. The fluorescent readings were recorded by a Packard 96-well
fluorocounter (485 nm excitation; 530 nm emission).
Where the O2 tension of the buffers were manipulated, the buffer
vehicle was continuously bubbled for 2 h at 20 °C with 100% O2 to
create conditions of increased O2 tension, or purged with argon (Ar) to
create anerobic conditions, prior to the addition of vitamin C or
polypeptide.
RESULTS
To establish whether Ab reduces Cu(II) to Cu(I), we used
three independent methods. In the first approach various Ab
peptides, vitamin C (as a positive control), and other control
polypeptides were incubated with Cu(II)-glycine chelate. Cu(I)
formation was monitored using a chromogenic Cu(I)-trapping
agent, BC. Ab1–42 and Ab1–40 were the only tested peptides
found to reduce significant amounts of Cu(II) to Cu(I) (gener-
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ating 6 and 3 mM, respectively) during the 1-h incubation period
(Fig. 1). Cu(II) was not significantly reduced (,1 mM) by rat/
mouse Ab1–40, reverse sequence human peptide (Ab40–1),
amylin, insulin, Ab1–28, or Ab25–35 (Fig. 1). Since it has been
pointed out that BC could also bind to Cu(II), potentially alter-
ing its reduction potential and cause artifactual estimates of
Cu(I) (23), we corroborated the apparent Cu(II)-reducing prop-
erties of Ab1–40/2 by comparing the assay results using BC to
those obtained with another Cu(I) detection agent, BCA. The
apparent amounts of Cu(I) generated by Ab1–42 and Ab1–40
using either BC or BCA were in excellent agreement (Fig. 1,
inset).
Secondly, EPR spectroscopy was used to measure residual
Cu(II) remaining after incubating stoichiometric ratios of
CuCl2 with Ab1–40. This peptide caused a loss of the Cu(II)
signal (76%), in relative agreement with the corresponding
Cu(I) detected in the bioassays above. The detection of Cu(I) by
BC assay, at levels roughly comparable to those estimated from
loss of the EPR signal for Cu(II), suggests that the EPR signal
was not disappearing due to formation of antiferromagnetically
coupled (S 5 0) dicopper species. Experimental EPR S-band
spectra (Fig. 2) and X- and Q-band spectra (data not shown)
establish that copper binds very tightly to these peptides.
Fig. 2A shows that an approximately equimolar mixture of
Ab1–40 and CuCl2 produces a single Cu(II)-peptide complex.
The multiple resonance signal shown in the EPR spectrum for
copper-peptide (Fig. 2A) is for a single Ab-bound Cu(II) species
that is paramagnetic. Spin quantitation employing a dual mode
TE104 X-band rectangular cavity revealed that this EPR signal
accounted for 24% of the added Cu(II), consistent with 76% of
the Cu(II) being converted to EPR-silent species, very likely
Cu(I). There was no evidence of free, uncomplexed Cu(II) re-
maining after addition of the peptide, since unbound Cu(II)
itself gives a different multiple resonance signal. The loss of
76% of the Cu(II) signal upon incubation with Ab1–40 is com-
patible with peptide-mediated reduction of Cu(II) to diamag-
netic Cu(I), which is undetectable.
Computer simulation of the experimental spectrum of
Ab1–40 with an axially symmetric spin Hamiltonian and the g
and A matrices (gi, 2.295; g', 2.073; Ai, 163.60, A', 10.0 3 10
24
cm21) yielded the spectrum shown in Fig. 2B. Expansion of the
MI 5 21/2 resonance revealed nitrogen ligand hyperfine cou-
pling. Computer simulation of these resonances indicated the
presence of at least three nitrogen atoms. The magnitude of the
gi and Ai values also suggest a tetragonally distorted geometry,
which is commonly found in type 2 copper proteins (24), and
together with the Blumberg Peisach plots, are consistent with
a fourth equatorial ligand binding to copper via an oxygen
rather than a sulfur donor atom. Thus, the coordination sphere
for the copper-peptide complex is CuN3O1.
The third line of independent evidence to support Ab-de-
pendent reduction of Cu(II) was the electrochemical behavior of
Cu(II), assessed in the presence and absence of Ab by cyclic
voltammetry (Fig. 3). This revealed that Ab1–42 (line c) gives
rise to a voltammetric response with a formal reduction poten-
tial of approximately 1500–550 mV (versus Ag/AgCl) in phos-
phate-buffered saline alone. This is an extraordinarily high
positive potential, which suggests a Cu(I) oxidation state that
is highly stabilized by the peptide. Our buffers, even after
careful preparation and filtration through Chelex-100 resin,
were found routinely to possess '0.1 mM copper background
contamination, as assessed by inductively coupled plasma
analysis (8). To determine whether interaction with this trace
quantity of metal ion was responsible for the electrochemical
response of Ab, we added CuCl2 (17 mM) to the solution. This
increased the magnitude of the response from the Ab1–42
solution (line d), consistent with this potential being character-
istic of a copper-Ab complex. Background voltammograms of
the PBS vehicle did not produce such peaks (line a), and Cu(II)
in PBS showed only a Cu(II/I) peak in the reduction wave at
'280 mV (line b) along with the return oxidation wave. This
reduction process was not observed when Cu(II) was added to
Ab1–42, consistent with the complete reaction of Cu(II) with
Ab.
Since Cu(I) can in principle reduce O2, we tested Ab peptides
in the presence of Cu(II) (1 mM) for direct production of H2O2.
We found that peroxide was indeed formed in these solutions,
FIG. 1. Ab-mediated Cu(II) reduc-
tion. Production of Cu(I) (BC assay) from
Cu(II)-glycine (25 mM) by Ab species, com-
pared with vitamin C, insulin, human
amylin (all 10 mM) in PBS, pH 7.4, after
1 h co-incubation, 37 °C. Data indicate
means 6 S.D., n 5 3. Inset, Cu(I) assay
validation. The amounts of Cu(I) gener-
ated by Ab1–42 and Ab1–40, under the
same conditions, were compared by two
different assays, BC with BCA.
FIG. 2. Electron paramagnetic resonance spectroscopy of a
Cu-Ab1–40 complex. A, experimental spectrum generated by adding
CuCl2 (280 mM) to Ab1–40 (323 mM) in PBS, pH 7.4. n 5 4.0663 GHz. B,
computer simulation of A.
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the amount of H2O2 produced in 1 h by the various Ab and
control peptides was greatest for Ab1–42 (10 mM) . Ab1–40
(7.5 mM) .. rat Ab1–40, Ab40–1, Ab25–35, Ab1–28, insulin,
and amylin ('0 mM) (Fig. 4A), paralleling the amounts of metal
reduction by the same peptides (Fig. 1). Validation of these
results was achieved by coincubating Ab with catalase, which
abolished the H2O2 signal in a dose-dependent manner, and
also by performing a corroborating assay using dichlorofluores-
cein (data not shown).
To investigate whether the formation of H2O2 by Ab was due
to the specific reduction of O2, we studied the generation of
H2O2 by Ab1–42, Ab1–40, and vitamin C under different O2
tensions in the presence of 1 mM Cu(II) (Fig. 4B). The presence
of vitamin C was used as a control measure to estimate the
maximum amount of H2O2 that could be detected in the buffer
vehicle by the non-protein generation of Cu(I). This experiment
confirmed that there was a significant dependence of H2O2
production upon the O2 tension. The presence of either Ab1–42
and Ab1–40 generated significantly more H2O2 (Ab1–42 .
Ab1–40) than vitamin C under any O2 tension studied, and
generated H2O2 under low O2 tension where vitamin C pro-
duced none. Under ambient and argon-purged conditions in
this system, the reduction of Cu(II) alone by the positive con-
trol, vitamin C, was insufficient to produce detectable H2O2.
Therefore, Ab facilitated the reduction of O2 more than would
be expected by the interaction of the Cu(I) reduced by Ab with
passively dissolved O2. Hence, Ab acts not only to reduce metal
ions, but also to trap molecular O2 to form H2O2. These data
also suggest that copper cycles between the oxidized and re-
duced forms when bound to Ab, since the presence of 1 mM
Cu(II) was sufficient to produce a catalytic amount (10 mM) of
H2O2 in 1 h, consistent with redox cycling and multiple electron
donation events from Cu(I) to molecular O2.
We examined Ab1–42 (10 mM) in Cu(II) (1 mM in PBS, pH 7.4)
for evidence of O2
2 formation over a 1 h incubation. Neither of
the O2
2-selective detection reagents hydroethidium (20 mM, Mo-
lecular Probes), nor nitro blue tetrazolium (NBT, 0.1 mM) de-
tected O2
2 formation from Ab, using xanthine (1 mM) with
xanthine oxidase (0.015 units/ml) in PBS as a positive control.
To prove that Ab-mediated H2O2 formation is metal-ion de-
pendent, H2O2 production by Ab1–42 in the presence of copper-
selective chelators was assayed (Fig. 4C). The presence of 200
mM BC or diethylenetriaminepentaacetic acid abolished Ab-
mediated H2O2 formation in the presence of 1 mM Cu(II). Tri-
ethylenetetramine dihydrochloride only decreased the forma-
tion of H2O2 by '50%, indicating that high affinity copper
chelators may only be able to interrupt these interactions if
they have sufficient stereochemical access to the bound copper
atom.
We tested the consequences of Cu(II)-Ab interaction upon
the survival of primary neuronal cultures. We found that the
combination of Ab1–42 with Cu(II)-glycine (each at 10 mM)
significantly potentiated Ab neurotoxicity (70% cell death in
the presence of copper, 40% in its absence) (Fig. 5A). The
presence of catalase slightly rescued the toxicity of the peptide
alone (30% cell death), but entirely rescued the fraction of
Ab1–42 toxicity that was enhanced by Cu(II), indicating that
FIG. 3. Electrochemical characterization of a complex formed
between Ab1–42 and copper. Electrochemical analysis by cyclic vol-
tametry of Ab1–42 with and without added Cu(II). Response obtained
from: a, Dulbecco’s PBS, pH 7.3; b, Cu(II) (17 mM) in buffer; c, Ab1–42
(100 mM) in buffer; d, Ab1–42 (100 mM) with added Cu(II) (17 mM) in
buffer. All cyclic voltammograms were obtained at an indium/tin oxide
electrode with a Ag/AgCl (1 M KCl) reference electrode.
FIG. 4. Production of H2O2 from Ab in the presence of Cu(II). A,
comparison of H2O2 generation in 1 h by variant Ab species: Ab1–42,
Ab1–40, rat Ab1–40, Ab40–1, Ab1–28, and Ab25–35, and control pep-
tides insulin and amylin (vehicle conditions as in Fig. 3a). B, H2O2
produced by Ab1–42, Ab1–40, and vitamin C in the presence of Cu(II)
(1 mM) (in PBS, pH 7.4, 1 h, 37 °C) under various dissolved gas condi-
tions. Ambient, no efforts were made to adjust the gas tension in the
bench preparations of the buffer vehicle; O2 and Ar, 100% O2 or Ar were
continuously bubbled through the PBS vehicle for 2 h (at 20 °C), before
the remainder of the incubation components were added. C, metal ion
dependence of H2O2 production by Ab1–42. The effects of chelators (200
mM) upon the Ab1–42-mediated generation of H2O2 in the presence of
Cu(II)-glycine (1 mM) was measured by the tris(2-carboxyethyl)phos-
phine hydrochloride assay (vehicle conditions as in A). All data points
are means 6 S.D., n 5 3.
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the potentiation of toxicity induced by the presence of Cu(II)
was mediated by H2O2. Catalase could not completely rescue
the toxicity of Ab1–42, even when catalase was used at higher
concentrations (2000 and 3000 IU, data not shown). Since
Cu(II)-glycine alone was not neurotoxic, these results strongly
support the possibility that Cu(II) interaction modifies Ab lead-
ing to enhanced H2O2-mediated neurotoxicity. The inability of
catalase to completely rescue the neurotoxicity caused by
Ab1–42 suggests that other neurotoxic mechanisms that are
not mediated by H2O2 may contribute up to 25% of the lethality
observed.
To confirm that Cu(II)-enhanced toxicity of Ab was mediated
by extracellular H2O2 production, we studied the effects of
Cu(II)-glycine supplementation upon the toxicity of the other
biologically occurring Ab species in primary neuronal culture,
comparing human Ab1–42 and Ab1–40 to rat Ab1–40 (Fig.
5B). In the absence of additional Cu(II), Ab1–42 was observed
to be more neurotoxic than both human and rat Ab1–40, whose
lethal effects were indistinguishable and marginal at the con-
centrations tested (10–25 mM). However, whereas additional
Cu(II) (10 mM) dramatically increased the toxicities of human
Ab1–42 and Ab1–40, additional Cu(II) did not enhance the
toxicity of rat Ab1–40. The Cu(II)-induced potentiation of Ab
toxicity therefore followed the relationship of Ab1–42 .
Ab1–40 .. rat Ab1–40, which parallels both Cu(II) reduction,
and the Cu(II)-mediated generation of H2O2, by the same pep-
tides. Taken together, these data argue that Cu(II) enhances
the neurotoxicity of Ab substantially through the cell-free gen-
eration of H2O2.
DISCUSSION
The experiments described above establish that Cu(II) is
reduced by Ab peptides, that Cu(I) mediates O2-dependent
cell-free H2O2 generation, and that these properties directly
correlate with the Cu(II)-mediated potentiation of Ab neuro-
toxicity in cell culture. Previously, we showed that concentra-
tions of Cu(II) at 5 1 mM induce the aggregation of Ab (17) and
generation of TBARS reactivity (6). The amounts of aggrega-
tion (17), TBARS reactivity (6), production of Cu(I) and H2O2,
as well as Cu(II)-enhanced neurotoxicity, are all greatest when
generated by Ab1–42 . Ab1–40 .. rat/mouse Ab1–40. This
relationship also correlates with the relative participation of
these peptides in amyloid pathology (10, 25), and in familial
AD-associated Ab processing (9, 26).
The absence of free Cu(II), determined by our EPR and
electrochemical studies following addition of Ab (Figs. 2 and 3),
indicates that both Ab1–40 and Ab1–42 have a high affinity
for Cu(II). In agreement with these findings, we recently esti-
mated the Kd for Cu(II) binding to Ab1–42 ('10
215 M) and
Ab1–40 ('10210 M).2 These observations strongly suggest the
possibility of a mediating role for even traces of redox active
metal ions in the neurotoxic properties of Ab1–40 and Ab1–42.
Addition of Cu(II) and Ab to cell cultures (Fig. 5, A and B)
certainly increased the observed neurotoxicity. Since most of
the added Cu(II) would be bound by the peptide within the
culture medium, we can conclude that neurotoxicity was medi-
ated via peptide-Cu(II) interactions rather than the effects of
free Cu(II) upon the cells.
The capacities of biological Ab peptides (Ab1–42, Ab1–40,
and rat Ab1–40) to reduce Cu(II) and to generate cell-free H2O2
(Figs. 1 and 4) correlated with Cu(II)-enhancement of the pep-
tides’ respective toxicities (Fig. 5B). This suggests that the
enhanced toxicity caused by Cu(II) supplementation was me-
diated by cell-free H2O2 production, especially since the in-
crease in toxicity caused by the presence of additional Cu(II)
was rescued by catalase (Fig. 5A). However, we also observed
that there was a component of neurotoxicity that could not be
rescued by catalase ('25%) and therefore may not have been
mediated by cell-free H2O2 production (Fig. 5A). Our data in-
dicate, therefore, that Ab1–40/2 toxicity has a lethal compo-
2 C. S. Atwood, R. C. Scarpa, R. E. Tanzi, and A. I. Bush, unpublished
observations.
FIG. 5. Cu(II) potentiates Ab neuro-
toxicity through hydrogen peroxide
formation. A, Ab1–42 (10 mM), Cu(II)-
glycine (10 mM) and/or catalase (1000
units/ml) were applied to embryonic day
17 rat forebrain primary neuronal cul-
tures, as indicated, and cell viability as-
sayed after 48 h. B, Ab peptide variants
(concentrations indicated) were applied to
embryonic day 17 rat forebrain primary
neuronal cultures and cell viability as-
sayed after 48 (left panel) or 72 (right
panel) h. A longer incubation at a higher
peptide concentration was required to ex-
hibit the copper-potentiated neurotoxicity
of Ab1–40. Data indicate mean cell sur-
vival (percentage of untreated cultures) 6
S.D., n 5 3. Asterisk indicates a signifi-
cant (p , 0.01) increase in Ab neurotox-
icity induced by Cu(II). Results are each
typical of four experiments.
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nent that is H2O2-mediated, and a lethal component that is not
H2O2-mediated.
Recently, we found that Fe(III) is also reduced by Ab (1–42 .
1–40 . rat Ab1–40) (6), but our current data indicate that
Cu(I) production under the same conditions, from the same
concentrations of metal ions and peptide, occurs to a signifi-
cantly greater extent than Fe(II) production. The stronger abil-
ity of Ab to reduce Cu(II) to Cu(I) is supported by an unusually
positive formal reduction potential for the Cu/Ab1–42 complex,
which is similar to that of small blue copper proteins (e.g.
laccase type 1-blue, 1555 mV, versus Ag/AgCl) and oxidases
(24), placing it among the extremes of copper-based biological
reducing activities.
The observation that Ab1–28 did not reduce Cu(II) (Fig. 1)
indicates that at least part of the hydrophobic carboxyl-termi-
nal domain (residues 29–40, possibly the methionine at resi-
due 35) is critical for the reduction properties of Ab. Redox
active cuproenzymes like superoxide dismutase usually bind
the active-site Cu(II) within b-sheet and b-barrel structures
(24). The increased b-sheet content caused by the two extra
hydrophobic residues (Ile and Ala) on Ab1–42 (30) may there-
fore increase the redox activity of Ab by enhancing Ab-copper
interaction. Ab-copper reduces O2 to peroxide under conditions
of low O2 tension (Fig. 4B), such as those expected in the brain
parenchyma. Since O2 is preferentially dissolved in hydropho-
bic environments (14), the hydrophobic carboxyl terminus of Ab
may create a microenvironment that facilitates electron trans-
fer from Cu(I) to O2, thereby promoting more H2O2 production
by Ab1–42 than by Ab1–40.
There are three ways in which H2O2 can form. A two-electron
transfer to O2 to generate the peroxide anion (O2
22), a one-
electron transfer generating the superoxide anion (O2
.) that
subsequently undergoes dismutation to H2O2, or two one-elec-
tron transfers from each of two coppers to a bridging dioxygen
molecule resulting in peroxide. The absence of a superoxide
intermediate indicates that, as with the case Fe(III)-mediated
H2O2 production (6), Cu(II)-mediated H2O2 production from Ab
must occur by either a double electron transfer from Cu(I) to O2
(generating Cu(III)), or by two successive one-electron trans-
fers. The simultaneous production of Cu(I) and H2O2 by Ab
raises the possibility of the hydroxyl radical (OHz) being formed
by Fenton chemistry as reported for superoxide dismutase 1
(31), and we have recently determined that Ab is carbonylated
by the decay of OHz in the presence of excess H2O2 and Cu(II).
3
A key novel finding of this work is that the cell-free genera-
tion of H2O2 by Ab depends upon only substoichiometric (cat-
alytic) amounts of metal ion (d1:10, copper:Ab), which lends
credence to the possibility of these reactions occurring in vivo.
The concentration of copper in the neocortex is '80 mM, and
that released during synaptic transmission is deduced to be
'15 mM (33). While free Cu(II) does not exist in the cytosol (34),
extracellular Cu(II) may be more readily exchangeable (24).
Cu(II) interaction with Ab may be exaggerated in AD where
copper levels are abnormally elevated in the neuropil (7, 36),
cerebrospinal fluid (37, 38), and especially in amyloid where
the concentration of copper has been measured at 30 mg/g ('0.5
mM, dry weight) (7). Extraction of copper may be the basis of
our recent discovery that copper-selective chelators, such as
bathocuproine, facilitate the solubilization of Ab from deposits
in post-mortem AD brain specimens (8). Therefore, the abnor-
mally high concentrations of copper in AD neuropil and in
amyloid may reflect a pathogenic neurochemical milieu that
both aggregates Ab and induces H2O2 production. Since H2O2
freely crosses cell boundaries, it is likely that its dissemination
from Ab deposits will contribute to oxygen radical-mediated
damage (39, 40), and inappropriate apoptotic signaling in AD
brain. Copper-dependent production of H2O2 from Ab accumu-
lations in the brain should now be examined in the context of
potential therapeutic intervention in AD.
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